A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 3, 1998, Pages 382-391

  Goodkin, Karl ^a   Feaster, Daniel J ^a   Asthana, Deshratn ^a   Blaney, Nancy T ^a   Kumar, Mahendra ^a   Baldewicz, Teri ^a   Tuttle, Raymond S ^a   Maher, Kevin J ^a   Baum, Marianna K ^a   Shapshak, Paul ^a   Fletcher, Mary Ann ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; BEREAVEMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HAMILTON SCALE; HEALTH CARE UTILIZATION; HEALTH STATUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROCORTISONE BLOOD LEVEL; IMMUNE STATUS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOCIAL SUPPORT; SUPPORT GROUP; UNITED STATES;

EID: 0031831580     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.3.382-391.1998     Document Type: Article

References (51)

1. American Psychiatric Association. 1987. Diagnostic and statistical manual of mental disorders III-revised. American Psychiatric Association, Washington. D.C.
2. Antoni, M. H., L. Baggett, G. Ironson, A. LaPerriere, S. August, N. Klimas, N. Schneiderman, and M. A. Fletcher. 1991. Cognitive-behavioral stress management intervention buffers distress responses and immunological changes following notification of HIV-1 antibody seropositivity. J. Consult. Clin. Psychol. 59:906-915.
3. Bartrop, R. W., L. Luckhurst, L. Lazarus, L. G. Kiloh, and R. Penny. 1977 Depressed lymphocyte function after bereavement. Lancet i:834-836.
4. Burack, J. H., D. C. Barrett, R. D. Stall, M. A. Chesney, M. L. Ekstrand, and T. J. Coates. 1993. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 270:2568-2573.
5. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
6. Carpenter, C. C. J., M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. G. Montaner, D. D. Richman, M. S. Saag, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, and P. A. Volberding, for the International AIDS Society-USA. 1996. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. JAMA 276:146-154.
7. Carver, C. S., M. F. Scheier, and J. K. Weintraub. 1989. Assessing coping strategies: a theoretically based approach. J. Pers. Soc. Psychol. 56:267-283.
8. Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mortal. Weekly Rep. 41(RR-17):1-19.
9. Chrousos, G. P., and T. Kino. 1997. The HIV-1 VPR gene product can cause glucocorticoid hypersensitivily or resistance: implications for the pathogenesis and clinical presentation of AIDS. Psychoneuroendocrinology 22(Suppl. 2):S160.
10. Clerici, M., M. Bevilacqua, T. Vago, M. L. Villa, G. M. Shearer, and G. Norbiato. 1994. An immunoendocrinological hypothesis of HIV infection. Lancet 343:1552-1553.
11. Conover, W. J., and R. L. Iman. 1981. Rank transformations as a bridge between parametric and nonparametric statistics. Am. Statistician 35:124-133.
12. Conover, W. J., and R. L. Iman. 1982. Analysis of covariance using the rank transformation. Biometrics 38:715-724.
13. Darj, E., O. Axelsson, K. Carlstrom, S. Nilsson, and B. von Schoultz. 1993. Liver metabolism during treatment with estradiol and natural progesterone. Gynecol. Endocrinol. 7:111-114.
14. Ebeling, P., and V. A. Koivisto. 1994. Physiological importance of dehydrocpiandrosterone. Lancet 343:1479-1481.
15. Evans, D. L., J. Leserman, D. O. Perkins, R. A. Stern, C. Murphy, K. Tamul, D. Liao, C. M. van der Horst, C. D. Hall, J. D. Folds, R. N. Golden, and J. M. Petitto. 1995. Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection. Am. J. Psychiatry 152: 543-550.
16. Farzadegan, H., M. A. Polis, S. M. Wolinsky, C. R. Rinaldo, J. J. Sninsky, S. Kwok, R. L. Griffith, R. A. Kaslow, J. P. Phair, B. F. Polk, and A. J. Saah. 1988. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. Ann. Int. Med. 108:785-790.
17. Faschingbauer, T. R., R. A. DeVaul, and S. Zisook. 1977. Development of the Texas Inventory of Grief. Am. J. Psychiatry 134:696-698.
18. Fletcher, M. A., G. C. Baron, M. R. Ashman, M. A. Fisehl, and N. G. Klimas. 1987. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn. Clin. Immunol. 5:69-81.
19. Folstein, M. F., S. E. Folstein, and P. R. McHugh. 1975. "Mini mental state". A practical method for grading the mental status of patients for the clinician. J. Psychiatry Res. 12:189-198.
20. Goodkin, K., J. Burkhalter, N. T. Blaney, B. Leeds, and D. J. Feaster. 1997. Bereavement support group techniques for the HIV infected: integration of research with clinical practice. Omega J. Death Dying 34:279-300.
21. Goodkin, K., N. T. Blaney, R. S. Tuttle, R. H. Nelson, T. Baldewicz, M. Kumar, M. A. Fletcher, B. Leeds, and D. J. Feaster. 1996. Bereavement and HIV infection. Int. Rev. Psychiatry 8:201-216.
22. Goodkin, K., D. J. Feaster, R. Tuttle, N. T. Blaney, M. Kumar, M. K. Baum, P. Shapshak, and M. A. Fletcher. 1996. Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men. Clin. Diagn. Lab. Immunol. 3:109-118.
23. Goodkin, K., M. A. Fletcher, and N. Cohen. 1995. Clinical aspects of psychoneuroimmunology. Lancet 345:183-184.
24. Goodkin, K., C. L. Mulder, N. T. Blaney, G. Ironson, M. Kumar, and M. A. Fletcher. 1994. Psychoneuroimmunology and HIV-1 infection revisited. Arch. Gen. Psychiatry 51:246-247.
25. Goodkin, K., N. T. Blaney, D. Feaster, M. A. Fletcher, M. K. Baum, E. Mantero-Atienza, N. Klimas, C. Millon, J. Szapocznik, and C. Eisdorfer. 1992. Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men. J. Psychosom. Res. 36: 635-650.
26. Hamilton, M. 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:56-61.
27. Hamilton, M. 1959. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:50-55.
28. Ingenbleek, Y., H.-G. ven den Schriek, P. de Nayer, and M. de Visscher. 1975. Albumin, transferrin, and the thyroxine-binding prealbumin/retinol-binding protein (TBPA-RBP) complex in assessment of malnutrition. Clin. Chim. Acta 63:61-67.
29. Irwin, M., M. Daniels, T. L. Smith, E. Bloom, and H. Weiner. 1987. Impaired natural killer cell activity during bereavement. Brain Behav. Immun. 1:98-104.
30. Kemeny, M. E., H. Weiner, R. Duran, S. E. Taylor, B. Visscher, and J. L. Fahey. 1995. Immune system changes after the death of a partner in HIV-positive gay men. Psychosom. Med. 57:547-554.
31. Kemeny, M. E., H. Weiner, S. E. Taylor, S. Schneider, B. Visscher, and J. L. Fahey. 1994. Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men. Health Psychol. 13:14-24.
32. Kiecolt-Glaser, J. K., and R. Glaser. 1988. Methodological issues in behavioral immunology research with humans. Brain Behav. Immun. 2:67-78.
33. Kumar, M., A. M. Kumar, R. Morgan, J. Szapocznik, and C. Eisdorfer. 1993. Abnormal pituitary-adrenocortical response in early HIV-1 infection. J. Acquired Immune Defic. Syndr. 6:61-65.
34. LaPerriere, A. R., M. H. Antoni, N. Schneiderman, G. Ironson, N. Klimas, P. Caralis, and M. A. Fletcher. 1990. Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self-Regul. 15:229-242.
35. 12 levels using radioisotope dilution and coated charcoal. Blood 36:202-208.
36. Licinio, J., P. W. Gold, and M.-L. Wong. 1995. A molecular mechanism for stress-induced alterations in susceptibility to disease. Lancet 346:104-106.
37. Lifshitz, M. S., and R. P. de Cresce. 1988. The QM-300 protein analysis system. Clin. Lab. Med. 8:633-642.
38. Lyketsos, C. G., D. R. Hoover, M. Gucciune, W. Senterfitt, M. A. Dew, J. Wesch, M. J. Van Raden, G. J. Treisman, H. Morgenstern, and the Multi-center AIDS Cohort Study. 1993. Depressive symptoms as predictors of medical outcomes in HIV infection. JAMA 270:2563-2567.
39. McNair, D. M., M. Lorr, and L. F. Droppleman. 1971. Profile of mood states manual. Educational and Industrial Testing Service, San Diego, Calif.
40. Milne, D. B., N. V. C. Ralston, and D. C. Wallionic. 1985. Zinc content of cellular components of blood: methods for cell separation and analysis evaluated. Clin. Chem. 31:65-69.
41. Root-Bernstein, R. S. 1995. Five myths about AIDS that have misdirected research and treatment. Genetica 95:111-132.
42. Roy, A., W. Gallucci, P. Avgerinos, M. Linnoila, and P. Gold. 1988 The CRH stimulation test in bereaved subjects with and without accompanying depression. Psychiatry Res. 25:145-146.
43. Sarason, I. G., B. R. Sarason, E. N. Shearin, and G. R. Pierce. 1987. A brief measure of social support: practical and theoretical implications. J. Soc. Pers. Relat. 4:497-510.
44. Sarason, I. G., J. H. Johnson, and J. M. Siegel. 1978. Assessing the impact of life changes: development of the life experiences survey. J. Consult. Clin. Psychol. 46:932-946.
45. SAS Institute, Inc. 1989. SAS/STAT user's guide, version 6, 4th ed, vol. 2. SAS Institute, Inc., Cary, N.C.
46. Skala, J. H., D. Gretz, and P. P. Waring. 1987. An automated continuous-flow procedure for simultaneous measurement of crythrocyte alanine and aspartate aminotransferase activities. Nutr. Rev. 7:731-741.
47. Spitzer, R. L., J. B. W. Williams, M. Gibbon, and M. B. First. 1988. Structured clinical interview for DSM-III-R: non-patient version for HIV studies (SCID-NP-HIV). New York State Psychiatric Institute, New York, N.Y.
48. Stein, M., A. H. Miller, and R. L. Trestman. 1991. Depression, the immune system, and health and illness: findings in search of meaning. Arch. Gen. Psychiatry 48:171-177.
49. Wilkie, F. L., C. Eisdorfer, R. Morgan, D. A. Loewenstein, and J. Szapocznik. 1990. Cognition in early human immunodeficiency virus infection. Arch. Neurol. 47:433-440.
50. Williams, J. B. W. 1988. Structured interview guide for the Hamilton-depression and anxiety scales (SIGH-AD). New York State Psychiatric Institute, New York, N.Y.
51. Zolla-Pazner, S., D. C. Des Jarlais, S. R. Friedman, T. J. Spira, M. Marmor, R. Holzman, D. Mildvan, S. Yancovitz, U. Mathur-Wagh, J. Garber, W. El-Sadr, H. Cohen, D. Smith, V. S. Kalyanaraman, J. E. Kaplan, and D. B. Fishbein. 1987. Non-random development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc. Natl. Acad. Sci. USA 84:5404-5408.